FDA review of drugs is slowing while application delays are growing, analysis finds

Taking stock of the drug industry, from the lab to the medicine chest

October 20, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | FDA review of drugs is slowing while application delays are growing, analysis finds The data signals a "risk we believe may not be fully appreciated given recent market highs," RBC Capital Markets analysts cautioned. By Ed Silverman STAT+ | CBO says revised cost of orphan drug exemptions will add $3.9 billion to Medicare The revision reflected the addition of three drugs — Keytruda, Opdivo, and Darzalex — that were not included in the original CBO estimate. By Ed Silverman STAT+ | Merck rolls out some showstoppers at a major cancer conference. Its future may depend on them Doctors applauded Merck's impressive Keytruda results and next-gen ADC data at ESMO 2025, a glimpse into how the firm sees its post-Keytruda future. By Andrew Joseph Andrew Joseph/STAT STAT+ | At ESMO, AstraZeneca and Gilead square off in triple-negative breast cancer At the ESMO Conference 2025, both companies reported successes in treating triple-negative breast cancer, with experts discussing which drug had the edge. By Andrew Joseph STAT+ | mRNA Covid shots may boost the effects of certain cancer treatments, study suggests Patients with advanced cancers who received a Covid vaccine before getting an immunotherapy drug lived significantly longer than patients who did not. By Angus Chen STAT+ | With questions surrounding its gastric cancer drug, Amgen fills in some gaps  Revised analysis of data on the drug, called bemarituzumab, had led to uncertainty about benefits, amid questions about possible safety issues as well. By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser